Unknown × Observational × Other hematologic neoplasm × Clear all Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
Unknown
1,000 enrolled
Is Ibrutinib-related Atrial Fibrillation Dose Dependent
Unknown
18,000 enrolled
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Unknown
500 enrolled
SKETCh
Unknown
650 enrolled
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
Unknown
40 enrolled
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Unknown
30 enrolled
MPL - NPM
Unknown
30 enrolled
COVIDVAC OH
Unknown
500 enrolled
Turkish Cultural Adaptation, Validity and Reliability of the "Gait Outcomes Assessment List"
Unknown
200 enrolled
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
Unknown
320 enrolled
Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients
Unknown
45 enrolled
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
Unknown
350 enrolled
Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial
Unknown
1,020 enrolled
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Unknown
954 enrolled
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Unknown
20 enrolled
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation
Unknown
100 enrolled
Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
Unknown
45 enrolled
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Unknown
300 enrolled
MASSAYA
Unknown
181 enrolled
Elattar
Unknown
100 enrolled
Immune Reconstitution After Allo-HSCT and Blinatumomab
Unknown
20 enrolled
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
Unknown
100 enrolled
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Unknown
60 enrolled
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
Unknown
300 enrolled
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Unknown
529 enrolled
TIPHI
Unknown
30 enrolled
CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
Unknown
600 enrolled
PeKiT
Unknown
500 enrolled
H19 in Acute Lymphoblastic Leukemia.
Unknown
96 enrolled
FDG-PETAML
Unknown
60 enrolled
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.
Unknown
30 enrolled
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
Unknown
5,000 enrolled
The Association of Gut Microbiota With COVID 19 Infection in Children
Unknown
40 enrolled
Ponderosa
Unknown
100 enrolled
Anti-mullerian Hormone in Acute Lymphoblastic Leukemia
Unknown
10 enrolled
GilteRInf
Unknown
78 enrolled
Frequency and Risk Factors of Acute Myeloid Leukemia
Unknown
200 enrolled
Changing Over Time of Ascorbic Acid After Chemotherapy
Unknown
150 enrolled
Real World Outcomes Using Novel Agents for AML in the UK
Unknown
1,000 enrolled
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
Unknown
53 enrolled
PBT
Unknown
80 enrolled
Leucosteo
Unknown
15 enrolled
Iclusig PMS in CML or Ph+ALL Patients
Unknown
50 enrolled
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management
Unknown
3,000 enrolled
THORUS
Unknown
28 enrolled
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias
Unknown
30 enrolled
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT
Unknown
37 enrolled
The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT
Unknown
60 enrolled
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Unknown
60 enrolled
The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project
Unknown
1,000 enrolled